| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/12/2002 | US6346386 Method of solution-based scanning for alterations in a DNA segment using a double-stranded DNA binding dye and fluorescence melting profiles |
| 02/12/2002 | US6346385 Analysis of predisposition based on human airway trypsin protease gene polymorphism |
| 02/12/2002 | US6346384 Real-time monitoring of PCR using LOCI |
| 02/12/2002 | US6346383 Advanced thermal gradient DNA chip (ATGC) the substrate for ATGC, method for manufacturing for ATGC method and apparatus for biochemical reaction and storage medium |
| 02/12/2002 | US6346382 Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto |
| 02/12/2002 | US6346381 Determination whether nucleotides from individual have one or more pg1-related biallelic markers or mutants; medical diagnosis |
| 02/12/2002 | US6346380 Diagnosing psychiatric, psychological, and nervous system disorders; amplification, molecular hybridization; genetic engineering |
| 02/12/2002 | US6346379 Thermostable DNA polymerases incorporating nucleoside triphosphates labeled with fluorescein family dyes |
| 02/12/2002 | US6346378 Nucleic acid analogs with a chelating functionality |
| 02/12/2002 | US6346373 Whole cell assay for cathepsin K activity |
| 02/12/2002 | US6346246 Antibodies that bind human haemopoietic maturation factor |
| 02/12/2002 | CA2259152C Adenovirus e4 proteins for inducing cell death |
| 02/12/2002 | CA2223776C Method of treatment for lung diseases using antisense oligonucleotides |
| 02/12/2002 | CA2215187C Addition of lactose or other sugars in correcting false susceptibility results for resistant microorganisms in antimicrobial susceptibility tests |
| 02/12/2002 | CA2066491C Human neurokinin-1 receptor |
| 02/10/2002 | CA2314398A1 Microarrays and microsystems for amino acid analysis and protein sequencing |
| 02/09/2002 | CA2354726A1 Sodium ion-driven chloride/bi-carbonate exchanger |
| 02/07/2002 | WO2002010766A2 Assay method, peptides and reagent kits for testing mrp-specific inhibitors |
| 02/07/2002 | WO2002010764A2 SPECIFIC BINDING AGENTS FOR KSHV vIL-6 THAT NEUTRALIZE A BIOLOGICAL ACTIVITY |
| 02/07/2002 | WO2002010763A2 Marker for antidepressant therapy and methods related thereto |
| 02/07/2002 | WO2002010762A1 A novel assay for determination of androgenic or anti-androgenic activity of a serum sample or a test compound |
| 02/07/2002 | WO2002010758A2 Surface-attached polyfunctional polymer networks for sensor chips |
| 02/07/2002 | WO2002010750A2 Biosensors, reagents and diagnostic applications of directed evolution |
| 02/07/2002 | WO2002010747A2 Method and apparatus for patch-clamp measurements on cells |
| 02/07/2002 | WO2002010746A2 Pharmacokinetic tool and method for predicting metabolism of a compound in a mammal |
| 02/07/2002 | WO2002010745A2 Cytological evaluation of breast duct epithelial cells retrieved by ductal lavage |
| 02/07/2002 | WO2002010744A1 Method of pretreating sample |
| 02/07/2002 | WO2002010741A2 Regional intestinal permeability model |
| 02/07/2002 | WO2002010736A1 Method for analysing nucleic acids |
| 02/07/2002 | WO2002010735A1 Biosensor |
| 02/07/2002 | WO2002010734A1 Biosensor |
| 02/07/2002 | WO2002010708A2 Hygiene monitoring |
| 02/07/2002 | WO2002010459A2 Three dimensional structure of paramyxovirus hemagglutinin-neuraminidases and use thereof |
| 02/07/2002 | WO2002010458A2 Method of performing subtractive hybridization |
| 02/07/2002 | WO2002010457A2 Targeting of dna sequences by the use of recombinase coated dna probes |
| 02/07/2002 | WO2002010456A2 Multiparameter analysis for predictive medicine |
| 02/07/2002 | WO2002010455A2 Methods for identifying genomic deletions |
| 02/07/2002 | WO2002010454A2 Haplotypes of the alas2 gene |
| 02/07/2002 | WO2002010453A2 Molecular toxicology modeling |
| 02/07/2002 | WO2002010452A2 Methods and compositions for predicting prostate cancer |
| 02/07/2002 | WO2002010450A2 Replicable probe array |
| 02/07/2002 | WO2002010449A2 Oligonucleotide library for detecting rna transcripts and splice variants that populate a transcriptome |
| 02/07/2002 | WO2002010447A2 Method for detecting nucleic acids by means of hybridization, use of this method and corresponding analysis kit and nucleic acid oligomers and use thereof |
| 02/07/2002 | WO2002010446A2 Method for determining a partial nucleotide sequence of a nucleic acid molecule |
| 02/07/2002 | WO2002010444A1 A method of detecting microorganisms |
| 02/07/2002 | WO2002010443A1 Combinatorial probes and uses therefor |
| 02/07/2002 | WO2002010442A1 Use of ectoenzymes and secreted enzymes to monitor cellular proliferation |
| 02/07/2002 | WO2002010440A1 Method of evaluating antifungal agent |
| 02/07/2002 | WO2002010439A2 Macromolecular enzyme substrates |
| 02/07/2002 | WO2002010438A2 Serial analysis of transcript expression using long tags |
| 02/07/2002 | WO2002010437A2 Synthetic and recombinant substrates for the detection of the von willebrand factor-cleaving protease |
| 02/07/2002 | WO2002010436A2 Prognostic classification of breast cancer |
| 02/07/2002 | WO2002010435A1 Methods of screening novel agents for use in cancer therapy and prevention |
| 02/07/2002 | WO2002010433A2 Method and device for detecting bacterial contamination |
| 02/07/2002 | WO2002010432A2 Triphosphate oligonucleotide modification reagents and uses thereof |
| 02/07/2002 | WO2002010404A2 Regulation of human masp-like serine protease |
| 02/07/2002 | WO2002010403A2 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme |
| 02/07/2002 | WO2002010402A2 Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| 02/07/2002 | WO2002010401A2 18431 and 32374, human protein kinase family members and uses therefor |
| 02/07/2002 | WO2002010393A2 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 02/07/2002 | WO2002010392A2 Mammalian dna binding membrane-associated protein-encoding gene and uses |
| 02/07/2002 | WO2002010388A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF |
| 02/07/2002 | WO2002010387A2 G-protein coupled receptors |
| 02/07/2002 | WO2002010382A2 Trp8, trp9 and trp10, markers for cancer |
| 02/07/2002 | WO2002010381A1 Novel protein inhibitor of apoptosis proteins |
| 02/07/2002 | WO2002010376A1 HUMAN II TYPE 5α-REDUCTASE PROMOTER GENE AND USE THEREOF |
| 02/07/2002 | WO2002010373A2 Apparatus and method for specific release of captured extension products |
| 02/07/2002 | WO2002010363A2 Protein phosphatases |
| 02/07/2002 | WO2002010359A1 A method of diagnosis abnormalities by screening for tyrosine kinase like molecules or their signalling mediators |
| 02/07/2002 | WO2002010358A2 Nucleotide incorporating enzymes |
| 02/07/2002 | WO2002010347A2 Directed differentiation of embryonic cells |
| 02/07/2002 | WO2002010341A1 Microsporidia isolate |
| 02/07/2002 | WO2002010340A1 $i(neospora caninum) isolate |
| 02/07/2002 | WO2002010339A2 Gene expression profile for kshv infection and methods for treating same |
| 02/07/2002 | WO2002010217A2 Endothelial cell expression patterns |
| 02/07/2002 | WO2002010216A2 Proteins and nucleic acids encoding same |
| 02/07/2002 | WO2002010205A2 Mutations of the mdr1 p-glycoprotein that improve its ability to confer resistance to chemotherapeutic drugs |
| 02/07/2002 | WO2002010199A2 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | WO2002010196A2 Identification of a novel glutamine transporter |
| 02/07/2002 | WO2002010186A1 A rapid, quantitative method for the mass spectrometric analysis of nucleic acids for gene expression and genotyping |
| 02/07/2002 | WO2002010138A2 Uses of mammalian genes and related reagents |
| 02/07/2002 | WO2002009868A2 Apparatus for generating a temperature gradient and methods for using the gradient to characterize molecular interactions |
| 02/07/2002 | WO2002009750A2 Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene |
| 02/07/2002 | WO2002009726A1 Methods of treating conditions associated with insulin resistance with aicar, (5-amino-4-imidazole carboxamide riboside) and related compounds |
| 02/07/2002 | WO2002009573A2 Prognostic classification of endometrial cancer |
| 02/07/2002 | WO2002009508A1 Nonhuman animal models non-responsive to mycoplasma-origin lipoprotein/lipopeptide |
| 02/07/2002 | WO2001083823A8 Methods and compositions for polynucleotide analysis using generic capture sequences |
| 02/07/2002 | WO2001080720A3 Methods and compositions for the diagnosis of schizophrenia |
| 02/07/2002 | WO2001079507A3 EXPRESSION-REGULATING SEQUENCES AND EXPRESSION PRODUCTS IN THE FIELD OF FILAMENTOUS FUNGI $i(CHRYSOSPORIUM) |
| 02/07/2002 | WO2001078652A3 Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| 02/07/2002 | WO2001075063A3 Haplotypes of the chrnb3 gene |
| 02/07/2002 | WO2001064937A3 Caspase-inhibitory-factor (cif) and uses thereof |
| 02/07/2002 | WO2001063543A8 Method and system for the assembly of a whole genome using a shot-gun data set |
| 02/07/2002 | WO2001061042A3 Composite membranes for assaying biomolecules |
| 02/07/2002 | WO2001060970A3 Zinc finger domains and methods of identifying same |
| 02/07/2002 | WO2001059127A3 Drug metabolizing enzymes |
| 02/07/2002 | WO2001057519A3 Method for identifying and/or characterizing a (poly)peptide |
| 02/07/2002 | WO2001055329A3 Nucleic acids, proteins, and antibodies |
| 02/07/2002 | WO2001055315A3 Nucleic acids, proteins, and antibodies |
| 02/07/2002 | WO2001055297A3 Three-dimensional matrix body, and device and method for measuring contractions of a cell tissue |